AstraZeneca
The Development Scientist III leads the development, qualification, and optimization of bioassay and process-derived impurity methods to support the release and stability testing of biotherapeutic products. This role involves drafting regulatory documentation for IND and BLA filings, leading cross-functional problem-solving, and implementing innovative automation to improve method throughput in a cGMP environment.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
44% above the average for this role
Director, Bioassay Development
Denali Therapeutics
QC Analyst Training Program Scientist
WuXi Biologics
Bioassay Scientist/Sr. Scientist, Analytical Development
Neurocrine Biosciences
Principal Scientist, Bioassay and Impurity Assay Development
Bristol Myers Squibb
QC Analyst Training Program
WuXi Biologics
QC Analyst Training Program
WuXi Biologics